Microcide Spins Off Genomics Firm With $12.5M Private Placement

Jan. 20, 1998

BioWorld briefs for April 6, 2026.

Hengrui discovers new Nav1.8 blockers

Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 31, 2026

Hematopoietic stem cell research points to leukemia’s early roots

BioWorld Science

Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...

Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis

BioWorld Science

Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...

Lisa Seachrist

ARTICLES

Victories For Biotechnology

Microcide Spins Off Genomics Firm With $12.5M Private Placement

Microcide Spins Off Genomics Firm With $12.5M Private Placement

Today's news in brief

Hengrui discovers new Nav1.8 blockers

News in brief

Hematopoietic stem cell research points to leukemia’s early roots

Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis